Translating findings on PM2.5 exposure, EGFR mutations, inflammation, and oxidative stress into clinical practice involves creating comprehensive screening and early detection guidelines tailored for nonsmokers at risk of lung cancer. Here, EGFR is linked to lung carcinoma.